UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————

FORM 8-K

———————

CURRENT REPORT

~~PURSUANT~~Pursuant TOto ~~SECTION~~Section 13 ORor 15(d) of OFthe ~~THE~~Securities Exchange Act of 1934

~~SECURITIES~~Date ~~EXCHANGE~~of ~~ACT~~Report OF(earliest ~~1934~~reported date): September 24, 2024

~~Date~~CS ofDIAGNOSTICS ~~Report: December 17, 2010~~CORP.

(~~Date~~Exact name of ~~earliest~~registrant ~~event~~as specified ~~reported~~in its charter)

———————

Wyoming		000-29611		20-1290331
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification Number)

~~THE~~Stresemannallee ~~CHILDREN’S INTERNET, INC.~~4b

~~(Exact~~Neuss ~~name of registrant as specified in charter)~~41460

~~———————~~Germany

~~NEVADA~~(Address of Principal Executive Offices) (Zip Code)

~~(State~~+49 ~~or other Jurisdiction of Incorporation or Organization~~(0)2131-151 08

~~000-29611~~Registrant's ~~(Commission~~telephone ~~File Number) 20-1290331 (IRS Employer Identification No.) 2377 Gold Meadow Way~~number, including ~~SUITE~~area ~~100 Gold River, CA 95670 (Address of Principal Executive Offices and zip~~ code)

(~~916~~Former name or former address, if changed since last report)~~631-1987~~

~~(Registrant's~~Check ~~telephone~~the ~~number,~~appropriate ~~including~~box ~~area~~below if ~~code)~~the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

~~N/A~~☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

~~(Former~~☐ Soliciting ~~Name~~material pursuant orto ~~Former~~Rule ~~Address,~~14a-12 ifunder ~~Changed~~the ~~Since~~Exchange ~~Last~~Act ~~Report~~(17 CFR 240.14a-12)

~~Check the appropriate box below if the Form 8~~☐ Pre-Kcommencement communications ~~filing~~pursuant ~~is intended~~ to ~~simultaneously~~Rule ~~satisfy~~14d-2(b) ~~the filing obligation of registrant~~ under ~~any~~the ofExchange ~~the~~Act ~~following~~(17 ~~provisions:~~CFR 240.14d-2(b))

¨☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Written~~Securities ~~communications~~registered pursuant to ~~Rule 425~~Section ~~under~~12(b) of the ~~Securities~~ Act: ~~(17 CFR 230.425)~~None

¨Title of each Class Trading Symbol Name of each exchange on which registered N/A FZRO OTC Market Group

~~Soliciting~~Indicate ~~material~~by ~~pursuant~~check tomark whether the registrant is an emerging growth company as defined in Rule ~~14a-12~~ 405 of the Securities Act of 1933 (b§230.405 of this chapter) ~~under~~or Rule 12b-2 of the Securities Exchange Act ~~(17~~of ~~CFR~~1934 (§240.~~14a~~12b-~~12(b~~2 of this chapter))

Emerging Growth Company ¨

~~Pre-commencement~~If ~~communications~~an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to ~~Rule 14d-2~~Section 13(ba) ~~under~~of the Exchange Act ~~(17 CFR 240~~.~~14d-2(b))~~ ¨

¨ITEM 8.01 - OTHER EVENTS

~~Pre-commencement~~CS ~~communications~~Diagnostics ~~pursuant~~Corp, a renowned member of the CS Group and medical distribution company dedicated to ~~Rule 13e-4(c)~~improving ~~under~~patient care through innovative solutions. By working closely with trusted global healthcare partners, experienced professionals and top universities CS Diagnostics Corp. is focused on prevention, improving therapy results by being safer and causing less side effects. One of such products is the ~~Exchange~~CS ~~Act~~Protect ~~(17~~Hydrogel. ~~CFR~~This ~~240~~novel spacer gel has been specially developed to separate healthy from malignant tissues during Radiation therapy, thereby significantly improving the chances of recovery for prostate cancer patients, for example.~~13e-4(c))~~ Increasing the effectiveness and safety of the therapy is giving patients much more comfort and Quality of life.

~~Safe~~Future ~~Harbor~~products ~~Statement~~are ~~under~~only included in the ~~Private~~CS ~~Securities~~Diagnostics ~~Litigation~~Corp. ~~Reform~~portfolio ~~Act~~after ofbeing ~~1995~~intensively tested to the highest standards.

~~Information~~CS ~~included~~Diagnostics inCorp. ~~this~~serves a ~~Form 8-K~~diverse ~~may~~international ~~contain~~market ~~forward-looking statements within the meaning of Section 27A of the Securities Act~~ and ~~Section 21E~~is ofwell ~~the~~experienced ~~Securities~~in ~~Exchange~~carrying ~~Act~~out ofcomplicated ~~1934,~~regulatory asprocedures ~~amended~~to ~~(the~~achieve ~~"Exchange~~product ~~Act"). This information may involve known~~ approvals and ~~unknown~~Marketing ~~risks,~~authorizations. ~~uncertainties~~Its ~~and~~global ~~other~~presence ~~factors~~strengthens ~~which~~strategic ~~may~~collaborations ~~cause~~with ~~the~~healthcare ~~actual~~providers ~~results,~~around ~~performance or achievements of The Children’s Internet, Inc. (~~the ~~“Company”) to be materially different from future results~~world, ~~performance~~ensuring that orits ~~achievements~~comprehensive ~~expressed~~services ~~or implied by any forward-looking statements. Forward-looking statements, which involve assumptions~~ and ~~describe~~solutions ~~future plans, strategies and expectations of the Companies,~~ are ~~generally~~available ~~identifiable~~in bymultiple use of the words "may," "will," "should," "expect," "anticipate," "estimate," "believe," "intend" or "project" or the negative of these words or other variations on these words or comparable terminologycountries. ~~Forward-looking~~With ~~statements~~a ~~are~~focus ~~based~~ on ~~assumptions~~quality ~~that may be incorrect,~~ and ~~there~~a ~~can~~broad berange noof ~~assurance~~solutions, CS ~~that~~Diagnostics ~~any~~Corp. ~~projections~~is orwell ~~other~~positioned ~~expectations included in any forward-looking statements will come~~ to ~~pass.~~transform ~~The actual results of~~ the ~~Company~~future ~~could differ materially from those expressed or implied by the forward-looking statements as a result~~ of ~~various~~healthcare ~~factors. Except as required~~ by ~~applicable~~delivering ~~laws,~~on the ~~Company~~promise ~~undertakes~~of nobetter ~~obligation~~health toand ~~update~~vitality through ~~publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future~~better technology.

~~Item~~Company ~~5.03~~Officers ~~Amendment~~& ~~to the Articles of Incorporation~~Contacts

~~Pursuant~~Thomas ~~to Article IV of the Company's Articles of Incorporation and Article VIII of the Company's Bylaws on October 18~~Fahrhoefer, 2010 the Company filed its Profit Corporation Articles of Amendment (the "Amendment") with the Wyoming Secretary of State, increasing its authorized common shares from 500 million to 50 billion at par $0.00001 and designated its 25 million Preferred B shares at a par value of $0.00001, inclusive in the 25 million Preferred Shares the Company designates a new series Preferred B stock which will have special rights and privileges. A copy of the Amendment and exhibit are attached hereto as Exhibit A.President

~~SIGNATURES~~Thomas Josef Migotsch, Vice President, COO

~~Pursuant~~Mohammad ~~to the requirements of the Securities Exchange Act of 1934~~EsSayed, ~~the~~Vice ~~Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~President, CFO

	The Children’s Internet, Inc.
Date: December 17, 2010	By:	/s/ RICHARD J. LEWIS III
		Richard J. Lewis III, Chief Executive Officer

Janel Luzana, Company Secretary

Mahmoud A. Al-Sayyed, Independent Director

Lauren Kate Ugur, Independent Director

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized.

	CS DIAGNOSTICS CORP.

	/s/ Mohammad EsSayed
	Mohammad EsSayed
	Title: Chief Financial Officer

	Dated: October 3, 2024

Filing Compare · CS DIAGNOSTICS CORP.